The association of sofosbuvir and daclatasvir for treating severe recurrence of HVC infection after liver transplantation: results from the large French prospective multicentric ANRS CO23 CUPILT cohort

被引：0

作者：

Fougerou-Leurent, C. ^{[1
]}

Coilly, A. ^{[2
]}

Veislinger, A. ^{[1
]}

Laforest, C. ^{[1
]}

Danjou, H. ^{[1
]}

Renault, A. ^{[1
]}

Duclos-Vallee, J. C. ^{[2
]}

De Ledinghen, V. ^{[3
]}

Houssel-Debry, P. ^{[4
]}

Duvoux, C. ^{[5
]}

Di Martino, V. ^{[6
]}

Radenne, S. ^{[7
]}

Rohel, A. ^{[8
]}

Diallo, A. ^{[8
]}

Pageaux, G. P. ^{[9
]}

Bellissant, E. ^{[1
]}

机构：

[1] CHU, CIC Inserm1414, Rennes, France

[2] Hop Paul Brousse, AP HP, UMR S785, Villejuif, France

[3] CHU, Hop Haut Leveque, Bordeaux, France

[4] CHU, Hop Pontchaillou, Rennes, France

[5] Hop Henri Mondor, AP HP, F-94010 Creteil, France

[6] CHU Besancon, Hop Jean Minjoz, F-25030 Besancon, France

[7] HCL, Hop Croix Rousse, Lyon, France

[8] ANRS, INSERM, Paris, France

[9] CHU Montpellier, Hop St Eloi, Montpellier, France

来源：

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

PM2-041

引用

页码：43 / 43

页数：1